Works matching DE "HYDROXYUREA"

Results: 810
    1

    Level of Healthcare Facility and Psychosocial Factors Influence Perceived Self-Efficacy for Appropriate Use of Hydroxyurea: Experience from Caregivers of Children with Sickle Cell Disease in Tanzania.

    Published in:
    Healthcare (2227-9032), 2025, v. 13, n. 13, p. 1500, doi. 10.3390/healthcare13131500
    By:
    • Ally, Mwashungi;
    • Kakoko, Deodatus;
    • Omsland, Tone Kristin;
    • Swai, Calvin;
    • Metta, Emmy;
    • Moen, Kåre;
    • Mmbaga, Elia John;
    • Leshabari, Melkizedeck;
    • Yonazi, Mbonea;
    • Jonathan, Agnes;
    • Makani, Julie;
    • Balandya, Emmanuel
    Publication type:
    Article
    2

    Alterations in the humoral immunophenotype in sickle cell disease.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 6, p. 1774, doi. 10.1111/bjh.20089
    By:
    • Vistica Sampino, E.;
    • Bonal, D. M.;
    • Chorzalska, A.;
    • Morgan, J.;
    • Nguyen, L.;
    • Yu, C.;
    • Rodriguez, A.;
    • De Vito, R.;
    • Pels, S.;
    • Sprinz, P. G.;
    • McGann, P.;
    • Lulla, R. R.;
    • Dubielecka, P. M.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 96, n. 3, p. 393, doi. 10.1007/s11060-009-9976-3
    By:
    • Dresemann, Gregor;
    • Weller, Michael;
    • Rosenthal, Mark A.;
    • Wedding, Ulrich;
    • Wagner, Wolfgang;
    • Engel, Erik;
    • Heinrich, Bernhard;
    • Mayer-Steinacker, Regine;
    • Karup-Hansen, Anders;
    • Fluge, Øystein;
    • Nowak, Anna;
    • Mehdorn, Maximilian;
    • Schleyer, Eberhard;
    • Krex, Dietmar;
    • Olver, Ian N.;
    • Steinbach, Joachim P.;
    • Hosius, Christian;
    • Sieder, Christian;
    • Sorenson, Greg;
    • Parker, Richard
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Melanoniquia debida a hidroxiurea.

    Published in:
    Acta Médica Peruana, 2024, v. 41, n. 2, p. 144, doi. 10.35663/amp.2024.412.2861
    By:
    • Pamo-Reyna, Oscar G.
    Publication type:
    Article
    17
    18
    19
    20
    21

    In-Depth Immunological Typization of Children with Sickle Cell Disease: A Preliminary Insight into Its Plausible Correlation with Clinical Course and Hydroxyurea Therapy.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 11, p. 3037, doi. 10.3390/jcm11113037
    By:
    • Giulietti, Giulia;
    • Zama, Daniele;
    • Conti, Francesca;
    • Moratti, Mattia;
    • Presutti, Maria Teresa;
    • Belotti, Tamara;
    • Cantarini, Maria Elena;
    • Facchini, Elena;
    • Bassi, Mirna;
    • Selva, Paola;
    • Magrini, Elisabetta;
    • Lanari, Marcello;
    • Pession, Andrea
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Scleroderma-like syndrome due to hydroxyurea.

    Published in:
    Clinical & Experimental Dermatology, 2012, v. 37, n. 7, p. 755, doi. 10.1111/j.1365-2230.2011.04326.x
    By:
    • García-Martínez, F. J.;
    • García-Gavín, J.;
    • Álvarez-Pérez, A.;
    • Alonso-González, J.;
    • Ginarte, M.;
    • Toribio, J.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50